The mitochondrial permeability transition pore and cyclophilin D in cardioprotection

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 7, 2011, Pages 1316-1322

  Di Lisa, Fabio ^a   Carpi, Andrea ^b   Giorgio, Valentina ^a   Bernardi, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Cardioprotection; Cyclophilin D; Heart; Mitochondria; Permeability transition

Indexed keywords

CYCLOPHILIN D; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REGULATOR PROTEIN;

CALCIUM HOMEOSTASIS; ENERGY METABOLISM; HEART DISEASE; HEART MUSCLE METABOLISM; HEART PROTECTION; HUMAN; IN VIVO STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CELL DEATH; CYCLOPHILIN A; CYCLOPHILINS; ENERGY METABOLISM; HEART DISEASES; HUMANS; MICE; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; REACTIVE OXYGEN SPECIES;

EID: 79957964641     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.031     Document Type: Review

References (100)

1. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 1995, 182:367-377.
2. Bernardi P., Petronilli V., Di Lisa F., Forte M. A mitochondrial perspective on cell death. Trends Biochem. Sci. 2001, 26:112-117.
3. Griffiths E.J., Halestrap A.P. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J. Mol. Cell. Cardiol. 1993, 25:1461-1469.
4. Griffiths E.J., Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem. J. 1995, 307:93-98.
5. Di Lisa F., Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc. Res. 2006, 70:191-199.
6. Halestrap A.P., Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim. Biophys. Acta 2009.
7. Baines C.P. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res. Cardiol. 2009, 104:181-188.
8. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., Elbelghiti R., Cung T.T., Bonnefoy E., Angoulvant D., Macia C., Raczka F., Sportouch C., Gahide G., Finet G., André-Fouët X., Revel D., Kirkorian G., Monassier J.P., Derumeaux G., Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 2008, 359:473-481.
9. Sinha Roy R., Madesh M., Davies E., Antonsson B., Danial N., Hajnoczky G. Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol. Cell 2009, 33:377-388.
10. Sileikyte J., Petronilli V., Zulian A., Dabbeni-Sala F., Tognon G., Nikolov P., Bernardi P., Ricchelli F. Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). J. Biol. Chem. 2011, 286:1046-1053.
11. Bernardi P., Krauskopf A., Basso E., Petronilli V., Blalchy-Dyson E., Di Lisa F., Forte M.A. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 2006, 273:2077-2099.
12. Rasola A., Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 2007, 12:815-833.
13. Halestrap A.P., Clarke S.J., Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc. Res. 2004, 61:372-385.
14. Zorov D.B., Juhaszova M., Yaniv Y., Nuss H.B., Wang S., Sollott S.J. Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc. Res. 2009, 83:213-225.
15. Nicolli A., Petronilli V., Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by matrix pH. Evidence that the pore open-closed probability is regulated by reversible histidine protonation. Biochemistry 1993, 32:4461-4465.
16. Linder M.D., Morkunaite-Haimi S., Kinnunen P.K., Bernardi P., Eriksson O. Ligand-selective modulation of the permeability transition pore by arginine modification. Opposing effects of p-hydroxyphenylglyoxal and phenylglyoxal. J. Biol. Chem. 2002, 277:937-942.
17. O'Shea K.M., Khairallah R.J., Sparagna G.C., Xu W., Hecker P.A., Robillard-Frayne I., Des R.C., Kristian T., Murphy R.C., Fiskum G., Stanley W.C. Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition. J. Mol. Cell. Cardiol. 2009, 47:819-827.
18. Giorgio V., Soriano M.E., Basso E., Bisetto E., Lippe G., Forte M.A., Bernardi P. Cyclophilin D in mitochondrial pathophysiology. Biochim. Biophys. Acta 2010, 1797:1113-1118.
19. Di Lisa F., Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J. Mol. Cell. Cardiol. 2009, 46:775-780.
20. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 2005, 280:18558-18561.
21. Basso E., Petronilli V., Forte M.A., Bernardi P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J. Biol. Chem. 2008, 283:26307-26311.
22. Azzolin L., von Stockum S., Basso E., Petronilli V., Forte M.A., Bernardi P. The mitochondrial permeability transition from yeast to mammals. FEBS Lett. 2010, 584:2504-2509.
23. Leung A.W., Halestrap A.P. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim. Biophys. Acta 2008, 1777:946-952.
24. Galat A. Peptidylproline cis-trans-isomerases: immunophilins. Eur. J. Biochem. 1993, 216:689-707.
25. Scorrano L., Nicolli A., Basso E., Petronilli V., Bernardi P. Two modes of activation of the permeability transition pore: the role of mitochondrial cyclophilin. Mol. Cell. Biochem. 1997, 174:181-184.
26. Argaud L., Gateau-Roesch O., Muntean D., Chalabreysse L., Loufouat J., Robert D., Ovize M. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J. Mol. Cell. Cardiol. 2005, 38:367-374.
27. Clarke S.J., McStay G.P., Halestrap A.P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J. Biol. Chem. 2002, 277:34793-34799.
28. Gomez L., Thibault H., Gharib A., Dumont J.M., Vuagniaux G., Scalfaro P., Derumeaux G., Ovize M. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1654-H1661.
29. L. Azzolin, N. Antolini, A. Calderan, P. Ruzza, O. Marin, S. Mammi, P. Bernardi, A. Rasola, Antamanide, a derivative of Amanita phalloides, is a novel desensitizer of the mitochondrial permeability transition pore, Plos One in press (2010).
30. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
31. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
32. Schinzel A.C., Takeuchi O., Huang Z., Fisher J.K., Zhou Z., Rubens J., Hetz C., Danial N.N., Moskowitz M.A., Korsmeyer S.J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl Acad. Sci. USA 2005, 102:12005-12010.
33. Li Y., Johnson N., Capano M., Edwards M., Crompton M. Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis. Biochem. J. 2004, 383:101-109.
34. Matas J., Young N.T., Bourcier-Lucas C., Ascah A., Marcil M., Deschepper C.F., Burelle Y. Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy. J. Mol. Cell. Cardiol. 2009, 46:420-430.
35. Lin D.T., Lechleiter J.D. Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. J. Biol. Chem. 2002, 277:31134-31141.
36. Rasola A., Sciacovelli M., Chiara F., Pantic B., Brusilow W.S., Bernardi P. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc. Natl Acad. Sci. USA 2010, 107:726-731.
37. Motohashi K., Koyama F., Nakanishi Y., Ueoka-Nakanishi H., Hisabori T. Chloroplast cyclophilin is a target protein of thioredoxin. Thiol modulation of the peptidyl-prolyl cis-trans isomerase activity. J. Biol. Chem. 2003, 278:31848-31852.
38. Ghezzi P., Casagrande S., Massignan T., Basso M., Bellacchio E., Mollica L., Biasini E., Tonelli R., Eberini I., Gianazza E., Dai W.W., Fratelli M., Salmona M., Sherry B., Bonetto V. Redox regulation of cyclophilin A by glutathionylation. Proteomics 2006, 6:817-825.
39. Gourlay L.J., Angelucci F., Baiocco P., Boumis G., Brunori M., Bellelli A., Miele A.E. The three-dimensional structure of two redox states of cyclophilin A from Schistosoma mansoni. Evidence for redox regulation of peptidyl-prolyl cis-trans isomerase activity. J. Biol. Chem. 2007, 282:24851-24857.
40. Linard D., Kandlbinder A., Degand H., Morsomme P., Dietz K.J., Knoops B. Redox characterization of human cyclophilin D: identification of a new mammalian mitochondrial redox sensor?. Arch. Biochem. Biophys. 2009, 491:39-45.
41. Connern C.P., Halestrap A.P. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 1994, 302:321-324.
42. Costa A.D., Jakob R., Costa C.L., Andrukhiv K., West I.C., Garlid K.D. The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J. Biol. Chem. 2006, 281:20801-20808.
43. Fischer G., Wittmann Liebold B., Lang K., Kiefhaber T., Schmid F.X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins [see comments]. Nature 1989, 337:476-478.
44. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989, 337:473-475.
45. Wang P., Heitman J. The cyclophilins. Genome Biol. 2005, 6:226.
46. Borel J.F., Feurer C., Magnee C., Stahelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 1977, 32:1017-1025.
47. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
48. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T- lymphocyte activation. Nature 1992, 357:695-697.
49. Walsh C.T., Zydowsky L.D., McKeon F.D. Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction. J. Biol. Chem. 1992, 267:13115-13118.
50. Zydowsky L.D., Etzkorn F.A., Chang H.Y., Ferguson S.B., Stolz L.A., Ho S.I., Walsh C.T. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci. 1992, 1:1092-1099.
51. Cereghetti G.M., Stangherlin A., Martins Test B.O. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl Acad. Sci. USA 2008, 105:15803-15808.
52. Wasilewski M., Scorrano L. The changing shape of mitochondrial apoptosis. Trends Endocrinol. Metab. 2009, 20:287-294.
53. Parra V., Eisner V., Chiong M., Criollo A., Moraga F., Garcia A., Hartel S., Jaimovich E., Zorzano A., Hidalgo C., Lavandero S. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovasc. Res. 2008, 77:387-397.
54. Ong S.B., Subrayan S., Lim S.Y., Yellon D.M., Davidson S.M., Hausenloy D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121:2012-2022.
55. Yu T., Sheu S.S., Robotham J.L., Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res. 2008, 79:341-351.
56. Wang J.X., Jiao J.Q., Li Q., Long B., Wang K., Liu J.P., Li Y.R., Li P.F. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 2011, 17:71-78.
57. Giorgio V., Bisetto E., Soriano M.E., Dabbeni-Sala F., Basso E., Petronilli V., Forte M.A., Bernardi P., Lippe G. Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J. Biol. Chem. 2009, 284:33982-33988.
58. Kang B.H., Plescia J., Dohi T., Rosa J., Doxsey S.J., Altieri D.C. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007, 131:257-270.
59. Eliseev R.A., Malecki J., Lester T., Zhang Y., Humphrey J., Gunter T.E. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J. Biol. Chem. 2009, 284:9692-9699.
60. Scorrano L., Ashiya M., Buttle K., Weiler S., Oakes S.A., Mannella C.A., Korsmeyer S.J. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2002, 2:55-67.
61. Di Lisa F., Kaludercic N., Carpi A., Menabò R., Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res. Cardiol. 2009, 104:131-139.
62. Di Lisa F., Menabò R., Canton M., Barile M., Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in post-ischemic reperfusion of the heart. J. Biol. Chem. 2001, 276:2571-2575.
63. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008, 88:581-609.
64. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., Aupetit J.F., Bonnefoy E., Finet G., André-Fouët X., Ovize M. Postconditioning the human heart. Circulation 2005, 112:2143-2148.
65. Ovize M., Baxter G.F., Di Lisa F., Ferdinandy P., Garcia-Dorado D., Hausenloy D.J., Heusch G., Vinten-Johansen J., Yellon D.M., Schulz R. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc. Res. 2010, 87:406-423.
66. Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005, 111:194-197.
67. Hausenloy D.J., Yellon D.M., Mani-Babu S., Duchen M.R. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H841-H849.
68. Hausenloy D.J., Yellon D.M. Preconditioning and postconditioning: united at reperfusion. Pharmacol. Ther. 2007, 116:173-191.
69. Javadov S.A., Clarke S., Das M., Griffiths E.J., Lim K.H., Halestrap A.P. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J. Physiol. 2003, 549:513-524.
70. Halestrap A.P., Clarke S.J., Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim. Biophys. Acta 2007, 1767:1007-1031.
71. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 2004, 113:1535-1549.
72. Hausenloy D.J., Lim S.Y., Ong S.G., Davidson S.M., Yellon D.M. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning. Cardiovasc. Res. 2010.
73. Hausenloy D., Wynne A., Duchen M.R., Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 2004, 109:1714-1717.
74. Vanden Hoek T.L., Becker L.B., Shao Z., Li C., Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 1998, 273:18092-18098.
75. Pain T., Yang X.M., Critz S.D., Yue Y., Nakano A., Liu G.S., Heusch G., Cohen M.V., Downey J.M. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ. Res. 2000, 87:460-466.
76. Petronilli V., Penzo D., Scorrano L., Bernardi P., Di Lisa F. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J. Biol. Chem. 2001, 276:12030-12034.
77. Murphy E., Steenbergen C. Preconditioning: the mitochondrial connection. Annu. Rev. Physiol 2007, 69:51-67.
78. Miura T., Tanno M., Sato T. Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc. Res. 2010, 88:7-15.
79. Hausenloy D.J., Lecour S., Yellon D.M. RISK and SAFE pro-survival signalling pathways in ischaemic postconditioning: two sides of the same coin. Antioxid. Redox Signal. 2010.
80. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc. Res. 2004, 61:448-460.
81. Lacerda L., Somers S., Opie L.H., Lecour S. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc. Res. 2009, 84:201-208.
82. Costa A.D., Garlid K.D., West I.C., Lincoln T.M., Downey J.M., Cohen M.V., Critz S.D. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ. Res. 2005, 97:329-336.
83. Perrino C., Feliciello A., Schiattarella G.G., Esposito G., Guerriero R., Zaccaro L., Del Gatto A., Saviano M., Garbi C., Carangi R., Di L.E., Donato G., Indolfi C., Avvedimento V.E., Chiariello M. AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. Cardiovasc. Res. 2010, 88:101-110.
84. Baines C.P., Song C.X., Zheng Y.T., Wang G.W., Zhang J., Wang O.L., Guo Y., Bolli R., Cardwell E.M., Ping P. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res. 2003, 92:873-880.
85. Churchill E.N., Murriel C.L., Chen C.H., Mochly-Rosen D., Szweda L.I. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ. Res. 2005, 97:78-85.
86. Steenbergen C., Das S., Su J., Wong R., Murphy E. Cardioprotection and altered mitochondrial adenine nucleotide transport. Basic Res. Cardiol. 2009, 104:149-156.
87. Heinzel F.R., Luo Y., Li X., Boengler K., Buechert A., Garcia-Dorado D., Di Lisa F., Schulz R., Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ. Res. 2005, 97:583-586.
88. Rottlaender D., Boengler K., Wolny M., Michels G., Endres-Becker J., Motloch L.J., Schwaiger A., Buechert A., Schulz R., Heusch G., Hoppe U.C. Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J. Clin. Invest. 2010, 120:1441-1453.
89. Clarke S.J., Khaliulin I., Das M., Parker J.E., Heesom K.J., Halestrap A.P. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ. Res. 2008, 102:1082-1090.
90. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., Schulz R., Heusch G. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ. Res. 2009, 104:15-18.
91. Burwell L.S., Nadtochiy S.M., Tompkins A.J., Young S., Brookes P.S. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 2006, 394:627-634.
92. Petronilli V., Miotto G., Canton M., Brini M., Colonna R., Bernardi P., Di Lisa F. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 1999, 76:725-734.
93. Bernardi P., Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J. Bioenerg. Biomembr. 1996, 28:131-138.
94. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 1999, 79:1127-1155.
95. Altschuld R.A., Hohl C.M., Castillo L.C., Garleb A.A., Starling R.C., Brierley G.P. Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes. Am. J. Physiol. 1992, 262:H1699-H1704.
96. Elrod J.W., Wong R., Mishra S., Vagnozzi R.J., Sakthievel B., Goonasekera S.A., Karch J., Gabel S., Farber J., Force T., Brown J.H., Murphy E., Molkentin J.D. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest. 2010, 120:3680-3687.
97. Lehman J.J., Kelly D.P. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail. Rev. 2002, 7:175-185.
98. Piao L., Fang Y.H., Cadete V.J., Wietholt C., Urboniene D., Toth P.T., Marsboom G., Zhang H.J., Haber I., Rehman J., Lopaschuk G.D., Archer S.L. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J. Mol. Med. 2010, 88:47-60.
99. Nakayama H., Chen X., Baines C.P., Klevitsky R., Zhang X., Zhang H., Jaleel N., Chua B.H., Hewett T.E., Robbins J., Houser S.R., Molkentin J.D. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 2007, 117:2431-2444.
100. Barsukova A., Komarov A., Hajnoczky G., Bernardi P., Bourdette D., Forte M. Activation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons. Eur. J. Neurosci. 2011, 33:831-842.